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Abstract
Background: Genetic association studies aim at finding correlations between a disease state and
genetic variations such as SNPs or combinations of SNPs, termed haplotypes. Some haplotypes
have a particular biological meaning such as the ones derived from SNPs located in the promoters,
or the ones derived from non synonymous SNPs. All these haplotypes are "subhaplotypes" because
they refer only to a part of the SNPs found in the gene. Until now, subhaplotypes were directly
computed from the very SNPs chosen to constitute them, without taking into account the rest of
the information corresponding to the other SNPs located in the gene. In the present work, we
describe an alternative approach, called the "global method", which takes into account all the SNPs
known in the region and compare the efficacy of the two "direct" and "global" methods.
Results: We used empirical haplotypes data sets from the GH1 promoter and the APOE gene, and
10 simulated datasets, and randomly introduced in them missing information (from 0% up to 20%)
to compare the 2 methods. For each method, we used the PHASE haplotyping software since it
was described to be the best. We showed that the use of the "global method" for subhaplotyping
leads always to a better error rate than the classical direct haplotyping. The advantage provided by
this alternative method increases with the percentage of missing genotyping data (diminution of the
average error rate from 25% to less than 10%). We applied the global method software on the
GRIV cohort for AIDS genetic associations and some associations previously identified through
direct subhaplotyping were found to be erroneous.
Conclusion: The global method for subhaplotyping can reduce, sometimes dramatically, the error
rate on patient resolutions and haplotypes frequencies. One should thus use this method in order
to minimise the risk of a false interpretation in genetic studies involving subhaplotypes. In practice
the global method is always more efficient than the direct method, but a combination method
taking into account the level of missing information in each subject appears to be even more
interesting when the level of missing information becomes larger (>10%).
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Background
Large-scale genomic studies are becoming a standard
nowadays. The exploitation of this huge body of data
leads to multiple biological applications and in particular,
to the unraveling of new molecular mechanisms for dis-
eases through the identification of genetic associations.
Genetic association studies are based on the comparison
of genetic markers, the most frequent ones being Single
Nucleotide Polymorphisms (or SNPs), between a dis-
eased group versus a healthy group (case-control study). If
a statistically significant difference is observed in the fre-
quency of a SNP allele between a group of patients and a
group of control subjects, it could mean that the gene or
its product is involved in disease development. Associa-
tion studies must also be performed on haplotypes which
are the combination of SNPs in a given locus. Indeed,
haplotypes and not only SNPs have already been reported
to be associated with complex diseases such as AIDS [1-4],
cancer [5-7], or Alzheimer's disease [8].
Experimental methods for haplotyping exist such as long-
range haplotyping [9], single-copy DNA genotyping in
conjunction with the Mass ARRAY system [10], or clone-
based systematic haplotyping [11] but they are not appli-
cable at a large scale level because of cost and time con-
sumption. As an alternative, computational approaches
have been developed to derive haplotypes from the SNP
genotypic information (the couple of alleles found for
each SNP) in a whole population. The most widely used
algorithms to infer haplotypes from the unphased geno-
typic data rely today on statistical approaches such as the
expectation-maximization (EM) algorithm or Bayesian
coalescence-based algorithms [12,13].
Haplotypes have been the subject of an increasing
number of studies in the recent years. Haplotypes infor-
mation makes it possible to highlight the structure of the
genome, notably through haploblocks which correspond
to segments of chromosomes unlikely to undergo a cross-
ing-over event [14,15]. In order to spare repeated efforts,
an international consortium has undertaken the HapMap
project with the aim of providing an exhaustive map
including the most important SNPs determining the most
frequent haplotypes in each haploblock of the human
genome. The Hapmap project could accelerate the detec-
tion of SNP alleles or haplotypes associated with a disease
phenotype [11].
The inference of haplotypes by computational methods
can be very difficult and even sometimes incorrect.
Indeed, the number of candidate haplotypes increases
exponentially with the number of polymorphic sites, this
number being 2n in a subject with n heterozygous SNPs.
Thus, it is not generally possible to solve correctly the
equations (infer their haplotypes) for all subjects espe-
cially when there are missing data (SNPs whose alleles are
unknown for some subjects in the population) which
happens in most experiments.
Recent studies have compared the various computational
methods to derive haplotypes [16-18]. Among them, the
PHASE software [19] seemed to yield better results
[13,16,20]. However, when haplotypes involving more
than 7 SNPs were estimated from unphased genotypes,
the reliability was poor even for PHASE, with an error rate
jumping as high as 10%. It can thus become very useful to
study haplotypes based on smaller set of SNPs in the pop-
ulation, which we will call here "subhaplotypes", because
of the higher degree of experimental reliability (less miss-
ing data) and the higher degree of accuracy (for the hap-
lotype computation).
It can also be important to investigate subhaplotypes with
regard to their putative biological function: for instance
subhaplotypes derived from SNPs in the gene promoter
region [21,22], derived from SNPs leading to a protein
mutation [21], or derived from tagSNPs [23-26]. Up to
now, subhaplotypes derived from a set of selected SNPs in
a gene have most often been inferred in a population by
using only the genotypic information of these very SNPs
in this population. However, an alternative approach
could be to estimate the haplotypes from all the SNPs
found in the gene and then, from these large haplotypes,
extract the subhaplotypes corresponding to the set of the
selected SNPs. In the case of missing information among
the SNPs this approach might be useful because the miss-
ing information can be compensated through the linkage
disequilibrium existing with other SNPs in the gene [27].
The first method, based on the direct haplotyping of SNPs
of interest, will be called the "direct method". The second
method, based on the use of larger haplotypes (haplo-
types containing a larger number of SNPs) to infer sub-
haplotypes will be called the "global method".
The purpose of the present study is to evaluate which sub-
haplotyping procedure was optimal by comparing them
on real and artificial genomic datasets. Such a compara-
tive evaluation has not been performed before and it is
particularly important for two reasons: 1. up to now most
reports on disease genetic association studies use the
"direct method" to estimate subhaplotypes [22,28-30]. 2.
Many groups focus only on a limited set of representative
SNPs such as tagSNPs to compute haplotypes [31,32]
when they could use a larger set of SNPs to compute hap-
lotypes more accurately.
Results
The goal of this study is to compare the two subhaplotyp-
ing strategies, "direct" and "global". For the comparison
of the two strategies, we have first used two real haplotypeBMC Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2156/7/50
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datasets previously determined experimentally: haplo-
types determined experimentally on 150 Caucasian sub-
jects in the GH1 gene and corresponding to 14 SNPs with
a MAF>1%, and haplotypes data determined experimen-
tally on 80 subjects of various ethnical backgrounds in the
APOE gene and corresponding to 9 SNPs with a MAF>1%.
These experimentally determined haplotypes have been
previously used as test samples by other researchers
[16,33,34]. We have also used 10 simulated haplotype
datasets artificially generated using a coalescent model on
30 SNPs and 100 individuals using the method of Schaff-
ner et al. [35]. All these datasets are described in more
details in Material and Methods. In order to look like real
genomic data we have also introduced artificially missing
information at various rates (2%, 5%, 10%, 15%, and
20%) in these datasets (see Material and Methods).
For the 2 methods, the computation of estimated haplo-
types was done with the PHASE software, previously
shown to be more reliable than the other haplotyping
software [13,16,20,36]. The comparison of the 2 subhap-
lotyping methods, "direct" and "global", was performed
with the following coefficients: the individual error rate
for haplotype assignment (the 2 haplotypes assigned to an
individual were correct or not), the similarity error rate
[13] which measures the number of mutations required to
obtain the real haplotypes for an individual, and the IF
coefficient which compares the estimated haplotype fre-
quencies with the real ones [37]. All these coefficients are
extensively described in Material and Methods.
Finally, we compared the impact of the use of the "global"
and the "direct" methods in real genomic data obtained
from an AIDS case-control study, the GRIV study, which
compares extreme profiles of progression to AIDS with
seronegative controls [38].
Comparison of the 2 methods in the GH1 haplotypes 
dataset
We tested various SNPs subsets of the GH1 data set to do
the comparison of the 2 subhaplotyping methods: we first
randomly generated 100 subsets with no missing data for
each size of 3, 5, and 7 SNPs. We then created randomly
missing data in the genotypic dataset at various rates of
2%, 5%, 10%, 15%, and 20%, 20 times for each rate (a
total of 100 genotypic datasets) and then, for each dataset,
we generated randomly 20 subsets for each size of 3, 5,
and 7 SNPs to compare the 2 methods after introducing
missing data (see Material and Methods). Overall, for a
given size of SNP subset (3, 5, or 7 out of the 14 SNPs) we
tested 100 samples with no missing information, and
2000 samples with missing information.
We compared the global and direct methods on the meas-
ure "maximal resolution" (Rmax) corresponding to the
haplotypes with the highest probability assigned by
PHASE. Interestingly, we noticed in these tests that PHASE
always managed to determine at least one possible resolu-
tion for each patient. Figure 1 shows graphs giving the
mean individual error rate (IER) of both methods accord-
ing to the rate of missing information. One may observe
that the global method appeared to systematically yield a
smaller mean error than the direct method (Figure 1).
Also, it was not surprising to observe that the level of error
of subhaplotype estimates produced by both methods
increased with the number of SNPs involved for subhap-
lotyping and with the level of missing information: a
range of 1 to 5% errors with no missing genotypic infor-
mation to a range of 5 to 25% errors with 20% of missing
genotypic information (Figure 1).
Table 1 further analyzes the difference between the 2
methods by presenting the similarity error rate (SimER)
and the IF coefficients (see Material and Methods): the glo-
bal method clearly yields better results.
Comparison of the 2 methods in other haplotypes datasets
We analyzed in the same way another real haplotype data-
set, previously published by Orzack et al. [33]. As shown
in Table 2, the global method again yields better results.
We also generated a population with artificial haplotypes
as described in Schaffner et al. [35], and found similarly
that the global method was more accurate (Table 2).
Interestingly, one can see that if the global method is
always better, the values of the IER, SER, and IF coefficients
obtained by each method are different between the GH1,
ApoE and artificial datasets for each level of missing infor-
mation (see Table 1 and 2). The genetic structure of the
population at stake appears thus to be very important.
Statistical significance
The results shown in Table 1 give the mean values of the
error levels, however it does not give the number of times
when the global method gets an error level lower than the
direct method. We did this computation and found for
the GH1 gene that the global method provided a more
accurate result in 87% of the tests with no missing infor-
mation, in 88% of the tests with 2% missing information,
in 90% of the tests with 5% missing information, in 92%
of the tests with 10% missing information, in 95% of the
tests with 15% missing information, in 97% of the tests
with 20% missing information. Similar results were
obtained for APOE and the simulated SNP data (data not
shown).
We also performed ANOVA tests to compare the IER
obtained by both methods on each subset of a given size
(GH1_3SNPs, GH1_5SNPs, GH1_7SNPs, APOE_4SNPs,
SIM1 to SIM10_10 SNPs). The results (data not shown)BMC Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2156/7/50
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show again that the IER obtained by the global method
are significantly better (p < 10-4) than the IER found by the
direct method for all subsets of SNPs.
Use of haplotypes defined through a Rmax cut-off
Since biologists often prefer to work with very clean data,
we decided to select the most likely resolutions produced
by PHASE. We thus selected those resolutions which
exhibited an output probability higher than either 50% or
70% (see Material and Methods). Table 3 shows the
results obtained by the direct and the global methods. For
both the 50% and the 70% cut-offs, the global method
yielded an error rate similar to the local method but it also
yielded many more resolutions (Table 3). The global
method with a 50% cut-off led to slightly more errors than
the global method at 70% cut-off, but it also yielded many
more resolutions (Table 3). Finally, when one compares
the results obtained with cut-offs (Table 3) with the
results obtained by Rmax (Table 1), it seems that the
number of resolutions obtained by Rmax (it is always
100%) is higher than the number of resolutions obtained
when using a cut-off, however the error rate is not as much
Graphical representation comparing the individual error rates (IER) between the direct and global methods Figure 1
Graphical representation comparing the individual error rates (IER) between the direct and global methods. 
This figure presents the detailed graphs of the average error rates obtained by the 2 subhaplotyping methods, "direct" (in 
white) and "global" (in black), when they rely on the resolution with maximum probability (Rmax) produced by PHASE. Each 
graph corresponds to a different level of missing data introduced in the GH1 genotypic dataset (0%, 2%, 5%, 10%, 15% and 
20%) and presents the mean of IER of all the replicates tested. There error rate obtained by the global method is always lower.
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different. In other words, the use of cut-offs leads to more
accurate resolutions but a smaller percentage of patients
gets subhaplotyped.
Combinations of the global method with the direct method 
according to the relative percentage of missing data
We reasoned that the localization of the missing informa-
tion in each patient could influence the output on the glo-
bal method versus that of the direct method. We thus tried
a last approach to optimize the quality of the results: com-
bining the global and direct methods when their results
for the most probable resolution (Rmax) are different for
a given patient (discordant subhaplotypes). For a patient,
if the missing information rate was higher among the very
SNPs selected for subhaplotyping, the subhaplotype pro-
vided by the global method was chosen; otherwise the
Table 1: Error rates obtained according to the level of missing information in the GH1 dataset
GH1
MD Method IER SimER IF Res rate
0% Global_3snp 1.12% 0.37% 0.994 100%
Local_3snp 1.56% 0.52% 0.9904 100%
Global_5snp 3.16% 0.65% 0.9834 100%
Local_5snp 3.57% 0.72% 0.9784 100%
Global_7snp 4.87% 0.74% 0.9714 100%
Local_7snp 5.57% 0.83% 0.9704 100%
2% Global_3snp 1.63% 0.38% 0.9937 100%
Local_3snp 2.57% 0.68% 0.9898 100%
Global_5snp 4.34% 0.88% 0.9826 100%
Local_5snp 5.26% 1.20% 0.9792 100%
Global_7snp 6.83% 0.82% 0.9693 100%
Local_7snp 8.70% 1.03% 0.961 100%
5% Global_3snp 2.03% 0.46% 0.9934 100%
Local_3snp 3.65% 0.79% 0.9894 100%
Global_5snp 5.40% 0.88% 0.98 100%
Local_5snp 7.68% 1.20% 0.972 100%
Global_7snp 8.43% 1.07% 0.967 100%
Local_7snp 11.00% 1.37% 0.959 100%
10% Global_3snp 3.57% 0.73% 0.989 100%
Local_3snp 6.60% 1.33% 0.983 99.87%
Global_5snp 8.06% 1.19% 0.973 100%
Local_5snp 12.91% 1.86% 0.962 100%
Global_7snp 11.84% 1.35% 0.959 100%
Local_7snp 16.41% 1.88% 0.946 100%
15% Global_3snp 5.21% 1.01% 0.987 100%
Local_3snp 9.49% 1.84% 0.977 99.45%
Global_5snp 10.67% 1.47% 0.97 100%
Local_5snp 17.00% 2.33% 0.953 100%
Global_7snp 15.70% 1.67% 0.953 100%
Local_7snp 21.87% 2.35% 0.931 100%
20% Global_3snp 6.65% 1.26% 0.984 98.44%
Local_3snp 12.45% 2.41% 0.97 97.02%
Global_5snp 12.83% 1.72% 0.964 100%
Local_5snp 22.15% 3.02% 0.936 99.60%
Global_7snp 18.47% 1.92% 0.946 99.72%
Local_7snp 26.44% 2.81% 0.916 100%
Summary of the mean error rates obtained by each subhaplotyping method when they used the Rmax resolution produced by PHASE. The average 
individual error rate (IER) and similarity error rate (SimER) were computed according to the level of missing data (MD) introduced in the 
population (0%, 2%, 5%, 10%, 15%, 20%). Tests were performed on randomly selected SNP subsets of size 3, 5, and 7 taken out of the 14 SNPs 
present in the GH1 genomic dataset (see text and Material and Methods). This table presents the average of the IF coefficients which compares the 
accuracy of the subhaplotypes frequencies found by each subhaplotyping method. The global method fares always better.BMC Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2156/7/50
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subhaplotype provided by the direct method was chosen
(see Material and Methods).
As shown in Table 4, the combination method gave a
rather good rate of error compared with the global
method but there were slightly less patients' haplotypes
resolved. Its use appeared most valuable when the
number of missing information was higher than 15%
(Table 4): the rate of error kept low (less than 7%), while
the number of resolved patients remained high (around
90%). The application of this method on the APOE gene
and on simulated data yielded similar results and conclu-
sions (data not shown).
Application to the analysis of subhaplotypes in an AIDS 
cohort
GRIV (Genetics of Resistance to immunodeficiency Virus)
is a case-control study comparing three groups, HIV-1
seropositive slow progressors (SP), HIV-1 seropositive
rapid progressors (RP) and seronegative controls (CTR)
[38]. We have previously published the exhaustive geno-
typing of SNPs from cytokines and cytokine receptors
genes in that cohort [2,22]. In these works, we had com-
puted the subhaplotypes derived from promoter SNPs by
using the direct method and the comparison of the distri-
bution of these subhaplotypes in the SP, RP, and CTR
groups had led to the identification of a few genetic asso-
ciations with AIDS progression. In the present study, we
have recomputed these subhaplotypes with the use of the
global method. We found that some positive signals (i.e.
associations) found by the direct method have disap-
peared when using the global method (IL4 Receptor and
IL10 Receptor [22]). On the contrary a test for association
that seemed to be negative for the promoter of IL6 became
significant [2]. All these results are summarized in Table 5.
As the global method has very often a lower error rate, we
conclude that the positive signals found in these studies
Table 2: Error rates obtained according to the level of missing information in the APOE and simulated datasets
APOE
MD Method IER SimER IF Res rate
0% Global 1.94% 0.45% 0.986 100%
Local 4.88% 1.22% 0.97 100%
2% Global 2.24% 0.48% 0.986 100%
Local 5.12% 1.19% 0.972 100%
5% Global 3.20% 0.54% 0.987 100%
Local 5.64% 1.83% 0.978 100%
10% Global 4.41% 0.68% 0.979 100%
Local 6.89% 1.91% 0.972 100%
15% Global 6.98% 1.09% 0.974 100%
Local 10.33% 1.97% 0.964 99.75%
20% Global 12.35% 2.09% 0.954 100%
Local 15.21% 2.54% 0.943 99.21%
Simulated
MD Method IER SimER IF Res rate
0% Global 0.14% 0.02% 0.996 100%
Local 0.81% 0.10% 0.989 100%
2% Global 0.19% 0.02% 0.989 100%
Local 1.26% 0.13% 0.982 100%
5% Global 0.25% 0.03% 0.982 100%
Local 1.46% 0.18% 0.975 100%
10% Global 0.46% 0.05% 0.968 100%
Local 2.65% 0.32% 0.961 100%
15% Global 0.83% 0.09% 0.954 100%
Local 4.80% 0.59% 0.947 100%
20% Global 1.51% 0.16% 0.941 100%
Local 8.70% 1.06% 0.934 100%
Summary of the average error rates found when working with subhaplotypes based on 4 SNPs out of 9 in the APOE genomic dataset and 10 SNPs 
out of 30 in the 10 simulated datasets.
IER: individual error rate, Res Rate: resolution rate, SimER: similarity error rate, MD: Missing data, IF: frequency error rate (see Material and 
Methods).BMC Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2156/7/50
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were likely to be artifacts of the direct subhaplotyping
while previously negative tests may have missed real asso-
ciations in AIDS progression.
Discussion and conclusion
In this study, we have confirmed that the error rate found
in the resolutions determined by the best haplotyping
software known to date, PHASE, could be non negligible
even when there were no missing information in the
genomic data [13,16,20,36]: it ranged from 1% to 6%
according to the selection of SNPs (see Table 1 and 2).
Errors were also observed at the level of the haplotypes
frequencies (Table 1 and 2). In reality, when dealing with
genotypic information obtained experimentally, there is
often missing information and our study shows that in
that case, the error rate for the estimation of haplotypes
can jump even higher, reaching 25% in some instances
(Table 1). This has led us to develop an alternative
method to estimate haplotypes, the "global method". The
rationale of the global method is to use the information
contained in other SNPs, which are not used in the direct
haplotyping, in order to limit the impact of missing data:
for instance, the presence of linkage disequilibrium
between SNPs might supplement missing data on certain
SNPs.
We performed tests on genomic datasets for which haplo-
types had been determined exactly through biological
experimentation and also on simulated data. We gener-
ated randomly missing genotypic information in these
datasets and computed partial haplotypes (subhaplo-
types) from subsets of selected SNPs. We found that the
global approach, which first computes the haplotypes
from all the available SNPs and then extracts the subhap-
Table 3: Error rates found by each method when using cut-offs for the probabilities provided by PHASE
GH1 – cutoff 70% (5 SNPs)
MD Method Abs IER Rel IER Res rate
0% Global 2.18% 2.24% 97.31%
Local 2.56% 2.65% 96.54%
2% Global 2.92% 2.99% 96.78%
Local 2.97% 3.05% 94.78%
5% Global 3.33% 3.49% 95.38%
Local 3.17% 3.51% 90.42%
10% Global 4.50% 4.92% 91.40%
Local 4.07% 5.00% 81.50%
15% Global 5.83% 6.56% 88.88%
Local 4.85% 6.42% 75.54%
20% Global 7.06% 8.14% 86.80%
Local 6.00% 8.81% 68.12%
GH1 – cutoff 50% (5 SNPs)
MD Method Abs IER Rel IER Res rate
0% Global 2.99% 2.99% 99.82%
Local 3.50% 3.50% 99.83%
2% Global 3.82% 3.98% 99.81%
Local 4.18% 4.26% 97.47%
5% Global 5.03% 5.06% 99.42%
Local 5.08% 5.32% 95.45%
10% Global 7.17% 7.28% 98.45%
Local 7.24% 8.04% 90.06%
15% Global 9.41% 9.62% 97.84%
Local 9.50% 10.95% 86.83%
20% Global 11.25% 11.58% 97.18%
Local 11.96% 14.45% 82.77%
This table presents the summary of average error rates when using a cut-off on resolution probability given by PHASE instead of Rmax when 
choosing the resolution obtained by each method. The 2 cut-offs chosen were respectively 50% and 70%. The error rate is almost always lower 
than with Rmax, but the number of assigned haplotypes strongly decreased.
IER: individual error rate, Abs IER: absolute IER, Rel IER: relative IER, Res Rate: resolution rate, MD: Missing Data.BMC Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2156/7/50
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lotypes corresponding to the selected SNPs, reproducibly
led to better estimations with significantly lower error
rates (Tables 1 and 2).
Since biologists like to work with exact data, we also tried
to work on the resolutions exhibiting a significant reliabil-
ity as determined by PHASE: resolutions exhibiting a
probability higher than 70% or higher than 50%. With
this approach, the global method still yielded a lower
error rate than the direct method (Table 3). It appears that
when one increases the cut-off to assign a resolution the
final error rate slightly diminishes while the number of
patients being assigned a subhaplotype diminishes rather
importantly (Table 3).
We finally tried to combine the global and direct methods
for discordant patients (patients for which the haplotypes
computed by the direct and global method were differ-
ent). For that, we used the subhaplotype computed by the
direct method if there was less missing information in the
SNPs selected for subhaplotyping than in the remaining
SNPs, or the global method in the opposite case. We
found that this combination method could be a useful
compromise when the level of missing information in the
population was high: the relative individual error rate was
smaller than that of the global method based on Rmax but
some patients were not assigned an haplotype (Table 4).
The fact that the global method yields better results than
the local method is not a surprise knowing the impor-
tance of linkage disequilibrium inside genetic loci.
Indeed, Marchini et al. found similarly that for the com-
putation of the r2 coefficients it was more reliable to use
large number of SNPs instead of pairwise comparisons
[20].
In practice, if there is not too much missing information
(less than 10%), the global method using the PHASE
Rmax resolution works well with nearly all subjects being
assigned a subhaplotype and with an error rate below
10% (Table 1 and 2). If there is more missing information
(more than 10%), it might be interesting to use the com-
bination method knowing that 90% of the subjects are
assigned a subhaplotype among which less than 8% have
a wrong haplotype (Table 4).
We have demonstrated the practical interest of this new
subhaplotyping method in our GRIV genomic dataset: we
had previously genotyped the cytokine and cytokine
receptors in the GRIV cohort and we had estimated sub-
haplotypes of the promoter regions by direct subhaplo-
typing [2,22]. In the present work, we have recomputed
the subhaplotypes of the promoter regions using the more
precise SUBHAP software: we found that associations pre-
viously described for IL4R, IL10R subhaplotypes did not
Table 4: Error rates of the combination method
Combination
MD Method Abs IER Rel IER SimER Res rate
2% combi_3snp 1.83% 1.84% 0.17% 100.00%
combi_5snp 2.56% 2.57% 0.36% 99.58%
combi_7snp 4.89% 4.89% 0.54% 99.23%
5% combi_3snp 2.72% 2.72% 0.29% 100.00%
combi_5snp 3.64% 3.69% 0.57% 98.39%
combi_7snp 6.09% 6.27% 0.60% 97.15%
10% combi_3snp 3.16% 3.22% 0.45% 98.06%
combi_5snp 5.60% 5.81% 0.68% 96.40%
combi_7snp 8.12% 8.54% 0.67% 95.12%
15% combi_3snp 5.03% 5.09% 0.61% 98.81%
combi_5snp 5.98% 6.31% 0.82% 94.70%
combi_7snp 6.62% 7.36% 0.77% 89.95%
20% combi_3snp 4.09% 4.56% 0.83% 89.78%
combi_5snp 8.16% 8.70% 0.96% 93.80%
combi_7snp 6.43% 7.34% 0.90% 87.54%
This table presents the summary of average error rates when using the combination method (see Material and Methods). In that case, we present 
the example of the results obtained for subsets of 5 SNPs.
IER: individual error rate, Abs IER: absolute IER, Rel IER: relative IER, SimER: similarity error rate, Res Rate: resolution rate, MD: Missing Data.BMC Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2156/7/50
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hold, while signals appeared much stronger for an IL6
subhaplotype (Table 5).
This work has extensively evaluated the impact of missing
data on subhaplotyping and it emphasizes that the level
of missing information in the genomic data is a critical
issue: the practical impact is not negligible since in our
experimental genotyping of the GRIV cohort, the rate of
missing data may reach 20% for some SNPs. Such rates
have also been widely described in the literature [39-41].
This work also underlines that the genetic structure of the
SNPs in the population is an important issue since the
error rates may vary from one population to the other (see
Table 1 and 2) and it could certainly be interesting to take
into account other parameters such as the LD and minor
allele frequencies to help optimize the subhaplotyping
procedure.
Current genomic studies, such as the Hapmap project,
aim at minimizing the number of SNPs necessary to per-
form genetic associations in complex diseases by using
tagSNPs. These studies do not consider the missing infor-
mation problem inherent to any genotyping experiment
which will often prevent the optimal haplotyping of the
patients for disease genetic association studies. Our results
suggest that if the Hapmap data are evidently very useful
in targeting genetic regions of interest, an extensive geno-
typing with all SNPs in a sensitive region will however
likely be needed to infer correct subhaplotypes.
In conclusion, the subhaplotyping method that we
described here will allow to improve genetic association
studies with complex diseases and take the best advantage
of the available genotype data. The global and combina-
tion methods are available with Subhap software [42].
Methods
The GH1 haplotypes data set
This haplotypic data set was determined empirically by
Haran et al. [34] from 154 patients who were recruited of
the British army. The promoter of the growth hormone
(GH1) gene spans 535 bps, and is very strongly polymor-
phic with 14 SNPs whose minor allele frequency (MAF) is
greater than 1% in the studied population. By cloning and
genotyping 154 patients [34], the authors managed to
experimentally define 38 different haplotypes based on
these 14 SNPs, including 18 haplotypes with a global fre-
quency higher than to 1%. We excluded the only patient
implicating a tri-allelic SNP to simplify the calculation: we
thus only used 153 patients of this cohort.
The GH1 gene SNPs presents only one perfect LD and
does not include any haploblock (Fig 1) which limits the
skewing of the results and makes this genomic dataset
more reliable for the comparison of the direct and global
methods.
The APOE haplotypes data set
This haplotypic dataset was determined experimentally by
Orzack et al. [33] using a long-range allele-specific PCR on
80 unrelated individuals from 3 ethnic groups: 18 Asian,
19 African and 43 Caucasian individuals. The APOE locus
is composed of 9 SNPs with MAF>1%. 17 haplotypes were
identified experimentally. The level of LD between the
APOE  SNPs was also very low, as for GH1  polymor-
phisms. The GH1 and APOE data sets are very useful for
Table 5: Modification of the results obtained in the GRIV case-control study when using the various subhaplotyping methods
Genes Sub-haplotype p-value direct Rmax subhap p-value global Rmax subhap p-value Combination Rmax subhap
IL10Receptor Exon 0.026
A.H cases: 100%
A.H controls: 100%
*0.103
A.H cases: 100%
A.H controls: 100%
0.093
A.H cases: 88%
A.H controls: 99%
IL4Receptor Promoter 0.019
A.H cases: 100%
A.H controls: 100%
*0.072
A.H cases: 100%
A.H controls: 100%
*0.088
A.H cases: 100%
A.H controls: 98%
IL6 Promoter 0.059
A.H cases: 100%
A.H controls: 100%
0.012
A.H cases: 100%
A.H controls: 100%
*0.009
A.H cases: 82%
A.H controls: 90%
*Best method regarding the missing data level.
This table presents the p-values found for the Fisher's exact tests comparing the subhaplotypes distributions between seropositive patients of the 
GRIV cohort (cases) and seronegative subjects (controls). The subhaplotypes were computed either with the direct Rmax method as previously 
published [2, 43], or with the global Rmax method, or with the combination Rmax method described in our study. The percentage of missing 
information was respectively 6.7%, 11.1% and 14.8% for the IL10R, IL4R, and IL6 genotypic data. One can see that some signals which were 
previously published as positive (p < 0.05) using the direct method become negative, while some signals which were previously published as negative 
become much stronger thanks to the novel subhaplotyping methods. For IL10R we have a deficit of information for cases and as consequences a 
lower percentage of assigned haplotypes in the combination method which is more restrictive.
A.H cases: percentage of assigned haplotypes attributed in the tests for cases
A.H control: percentage of assigned haplotypes attributed in the tests for controls.BMC Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2156/7/50
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our goal. Indeed, if we show that the global method is
more efficient on them, that advantage will be even
stronger for common datasets because they generally
exhibit more LD.
The simulated haplotypes data set
This haplotypic data was created with COSI package
developed by Schaffner et al. [35] based on a coalescent
model. We have generated 10 data sets of 30 SNPs on 100
unrelated individuals simulated with constant recombi-
nation rate across the region, constant population size,
and random mating.
The GRIV data sets
The GRIV cohort is composed of 400 Caucasian HIV-1
positive patients with extreme profiles of progression to
AIDS (Slow Progression or Rapid Progression) and has
been extensively genotyped by PCR-sequencing on vari-
ous genes of the immune system [38]. In addition, 400
healthy subjects of similar ethnic origin were also geno-
typed as controls (CTR). In the present study, we have
used the genotypes obtained on genes analyzed in the
cohort and previously reported: cytokines and their recep-
tors [2,43]. Unlike the GH1 and APOE data sets previously
described, we do not dispose of the real haplotypes for
this population.
Creation of missing data
The data set from the GH1 study was a complete data set.
In order to study the influence of missing data on the
accuracy of the results, missing data were artificially gen-
erated inside the GH1 data set. To be more realistic, miss-
ing data was distributed randomly across genomic
datasets. We applied similar levels of missing data to the
GH1, APOE and simulated datasets: 2%, 5%, 10%, 15%
and 20%.
Haplotyping software
We have chosen to use the PHASE software [13,19] to
infer haplotypes. Indeed, many studies some of which
performed on the GH1 datasets have compared the differ-
ent haplotyping algorithms and came to the conclusion
that the PHASE algorithm performed better [16, 17, 44,
45] with a lower error rate and a higher number of solved
patients. PHASE is based on a Markov chain of Monte
Carlo with a recombination model based on the decay of
LD with distance. The PHASE parameters were optimized
using the empirical haplotypes of the GH1 promoter: the
thinning interval (steps through the Markov chain per
iteration) and the number of runs (of the algorithm)
didn't seem to alter significantly the results. The number
of iterations on these data which apparently yielded the
lowest error rate and the best number of inferred haplo-
types was 100 iterations and 1000 burn-in (100, 500 and
10000 iterations were tested). The other parameters were
set by default.
Subjects with more than 50% missing information were
removed in order to avoid estimating haplotypes when
there was too much data lacking.
Subhaplotyping methods tested
The direct method
A subset containing only the genotypes of the selected
SNPs was extracted from the whole data set for all the
individuals. The haplotypes for these SNPs were then
inferred by haplotyping this data set with the PHASE soft-
ware.
The global method
The haplotypes were first inferred with the PHASE algo-
rithm from the whole data set containing all the SNPs
genotypes in each gene. This initial haplotyping provides
for each patient the diplotype derived from all the SNPs
and encompasses automatically the SNPs selected for sub-
haplotyping. The subhaplotypes corresponding to the
selected SNPs could then be extracted directly from this
global data set, forming the subhaplotype data set.
The combination method
When the two methods disagree on the resolution for one
patient, a resolution was chosen after assessing which
method was the most reliable.
In the case of the combination method based on the Rmax
resolution, the choice of the resolution depended on the
rate of missing information in the SNPs used to estimate
the subhaplotype. If the missing information was higher
than 30% both in SNPs composing the subhaplotype and
in the remaining ones used for the global method, we
considered that the patient's haplotypes could not be
solved.
Comparison of the resolutions found by each method with 
the real subhaplotypes
The results obtained when using each subhaplotyping
method were compared to the real subhaplotypes as
determined experimentally. This comparison was done by
using various coefficients measuring the error rate that are
described in the paragraphs hereafter. We have used the
ANOVA model to test if there was any statistical difference
between the error rates obtained from the two methods.
IER and SimER: error rates for haplotype assignments
The resolution rate (Res Rate) is the proportion of individ-
uals for which a diplotype was found by the subhaplotyp-
ing method. Res Rate thus ranges from 0 to a maximum of
1 when all patients are assigned an haplotype.BMC Genetics 2006, 7:50 http://www.biomedcentral.com/1471-2156/7/50
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The individual error rate (IER) is the proportion of sub-
jects whose inferred diplotype is not correct. In case the
Res Rate was <1, we called relative IER (Rel IER) the pro-
portion of subjects whose inferred diplotype is not correct
among all the subjects who were assigned a diplotype. In
case the Res Rate was <1, we called absolute IER (Abs IER)
the proportion of subjects whose inferred diplotype was
not correct among the whole population.
The similarity error rate (SimER) is another measure of
similarity between the estimated haplotypes and real hap-
lotypes, which was developed by Stephens et al. [13]: it is
based on the percentage of errors found at the level of
SNPs for each haplotype.
IF: error rate for the frequencies of the attributed haplotypes
IF [37] measure how closely the inferred and empirical
haplotype frequencies correspond and is given by:
where pek and ptk are the inferred and empirically deter-
mined frequencies for the kth  haplotype, and h  is the
number of haplotypes. IF range from 0 to a maximum
value of 1 when the frequencies match perfectly
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